Evaluation of adherence to drug treatment in patients with systemic lupus erythematosus in Brazil

被引:35
|
作者
Oliveira-Santos, M. [1 ,2 ]
Verani, J. F. S. [1 ]
Klumb, E. M. [2 ]
Albuquerque, E. M. N. [2 ]
机构
[1] Fundacao Oswaldo Cruz, Escola Nacl Saude Publ Sergio Arouca, Dept Epidemiol & Metodos Quantitativos Saude, Rio De Janeiro, Brazil
[2] Univ Estado Rio de Janeiro, Hosp Univ Pedro Ernesto, BR-20550011 Rio De Janeiro, Brazil
关键词
adherence to drug treatment; systemic lupus erythematosus; hierarchical multivariate analysis; RECOMMENDATIONS; MEDICATIONS; AMERICAN;
D O I
10.1177/0961203310383736
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The objectives of this study were to measure the prevalence of adherence to drug treatment and analyze associations with characteristics pertaining to the treatment, disease, health professionals and services, and socio-demographic issues in patients with systemic lupus erythematosus (SLE) in the city of Rio de Janeiro, Brazil. A sample of 246 women with SLE was analyzed. The data were collected through individual interviews and a review of patient charts. Adherence was estimated according to the Morisk criteria, and the associated factors were analyzed by hierarchical modeling. The percentage of patients classified as adherent to treatment was 31.7%. The reasons cited for non-adherence were: carelessness with drug administration times (52.43%), forgetfulness (38.21%), adverse drug reaction (13.8%), and interruption of treatment due to improvement in symptoms (7.72%). Factors associated with adherence were: behavior towards the presence of adverse drug reaction, hematological alterations, presence of mucocutaneous manifestations, legibility of the medical prescription, schooling, and family support. The study concludes that adherence to drug treatment in SLE is a complex and multifactorial phenomenon, and the results corroborate findings from studies conducted in developed countries. The hierarchical modeling proved to be a good alternative for evaluating adherence, since it allowed visualizing the various stages in the analysis. Lupus (2011) 20, 320-329.
引用
收藏
页码:320 / 329
页数:10
相关论文
共 50 条
  • [41] Frequency of adverse drug reactions in patients with systemic lupus erythematosus
    Pope, J
    Jerome, D
    Fenlon, D
    Krizova, A
    Ouimet, J
    JOURNAL OF RHEUMATOLOGY, 2003, 30 (03) : 480 - 484
  • [42] Drug monitoring in systemic lupus erythematosus
    Petri, Michelle
    CURRENT OPINION IN PHARMACOLOGY, 2022, 64
  • [43] INITIAL PRESENTATION OF SYSTEMIC LUPUS ERYTHEMATOSUS IN 286 PATIENTS IN SOUTHERN BRAZIL
    Skare, Thelma L.
    Gameiro Silva, Marilia Barreto
    Casagrande, Daniel
    Castro, Grace Arrielo
    ACTA REUMATOLOGICA PORTUGUESA, 2009, 34 (04): : 679 - 680
  • [44] Impact of Psychiatric Diagnosis and Treatment on Medication Adherence in Youth With Systemic Lupus Erythematosus
    Chang, Joyce C.
    Davis, Alaina M.
    Klein-Gitelman, Marisa S.
    Cidav, Zuleyha
    Mandell, David S.
    Knight, Andrea M.
    ARTHRITIS CARE & RESEARCH, 2021, 73 (01) : 30 - 38
  • [45] The Impact of Psychiatric Diagnosis and Treatment on Medication Adherence in Youth with Systemic Lupus Erythematosus
    Chang, Joyce
    Davis, Alaina
    Klein-Gitelman, Marisa
    Cidav, Zuleyha
    Mandell, David
    Knight, Andrea
    ARTHRITIS & RHEUMATOLOGY, 2020, 72 : 53 - 55
  • [46] Effectiveness of pharmaceutical care for drug treatment adherence in patients with systemic lupus erythematosus in Rio de Janeiro, Brazil: study protocol for a randomized controlled trial (vol 17, 181, 2016)
    Oliveira-Santos, M.
    TRIALS, 2017, 18
  • [47] Factors influencing adherence to medications in a group of patients with systemic lupus erythematosus in Jamaica
    Chambers, S.
    Raine, R.
    Rahman, A.
    Hagley, K.
    De Ceulaer, K.
    Isenberg, D.
    LUPUS, 2008, 17 (08) : 761 - 769
  • [48] Medication adherence, depression and disease activity among patients with systemic lupus erythematosus
    Alsowaida, N.
    Alrasheed, M.
    Mayet, A.
    Alsuwaida, A.
    Omair, M. A.
    LUPUS, 2018, 27 (02) : 327 - 332
  • [49] Significant others as informants of adherence and health status in patients with systemic lupus erythematosus
    Guice, D
    Lumley, M
    Gillis, M
    Mosley-Williams, A
    Leisen, J
    PSYCHOSOMATIC MEDICINE, 1999, 61 (01): : 90 - 90
  • [50] PREVALENCE AND ADHERENCE TO THERAPY FOR OSTEOPOROSIS AND CARDIOVASCULAR COMORBIDITIES IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS
    Panafidina, T.
    Popkova, T.
    Aristova, M.
    Gorbunova, Y.
    Lila, A.
    AGING CLINICAL AND EXPERIMENTAL RESEARCH, 2023, 35 : S519 - S519